John Meekison, Director
Mr. Meekison is a founder and Chief Financial Officer of Vancouver-based iCo Therapeutics Inc. (“iCo”), a biopharmaceutical company developing clinical stage drugs for ophthalmic (eye) diseases. In his capacity as Chief Financial Officer, he manages all accounting, finance, risk management, investor relations and human resource activities for iCo. He also works closely with the rest of the iCo’s executive team in business strategy, license renegotiations, and merger and acquisitions activities.
Mr. Meekison is a veteran investment banker with a specialization in both the life sciences and technology sectors at Haywood Securities Inc., Diouhy Merchant Group Inc., and Pacific International Securities Inc. (now PI Financial Corp.). As a financier, Mr. Meekison raised equity capital for various biotechnology and technology companies in both Canada and the United States. He has also acted as the Chief Financial Officer for a TSX-listed company developing a novel clinical diagnostic platform, where he supervised all public reporting, accounting, and finance functions. Mr. Meekison received his Bachelor of Arts from the University of British Columbia and is a certified Investment Manager and Professional Logistician.
